<DOC>
	<DOCNO>NCT02648204</DOCNO>
	<brief_summary>This trial conduct globally . The aim trial investigate efficacy safety semaglutide versus dulaglutide add-on metformin subject type 2 diabetes .</brief_summary>
	<brief_title>Efficacy Safety Semaglutide Versus Dulaglutide add-on Metformin Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Dulaglutide</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Immunoglobulin Fc Fragments</mesh_term>
	<criteria>Male female , age least 18 year time signing informed consent . HbA1c ( glycosylated haemoglobin ) 7.0 10.5 % ( 53 91 mmol/mol ) ( inclusive ) Subjects stable diabetes treatment metformin ( minimum 1500 mg/day maximal tolerate dose document patient medical record ) 90 day prior screen Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method ( adequate contraceptive measure require local regulation practice ) Any condition , investigator 's opinion might jeopardise subject 's safety compliance protocol Treatment medication indication diabetes obesity state inclusion criterion period 90 day screen . An exception shortterm insulin treatment acute illness total equal 14 day History pancreatitis ( acute chronic ) Screening calcitonin equal 50 ng/L Family personal history Multiple Endocrine Neoplasia Type 2 Medullary Thyroid Carcinoma Renal impairment define eGFR ( electronic case report form ) 60 mL/min/1.73 m^2 per CKDEPI ( Chronic Kidney Disease Epidemiology Collaboration ) Subjects presently classified New York Heart Association Class IV Planned coronary , carotid peripheral artery revascularisation day screen Proliferative retinopathy maculopathy require acute treatment History presence malignant neoplasm within last 5 year ( except basal squamous cell skin cancer insitu carcinoma ) Anticipated initiation change concomitant medication ( 14 consecutive day frequent basis ) know affect weight glucose metabolism ( e.g . orlistat , thyroid hormone , corticosteroid )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>